More than 85% of voters surveyed by Alzheimer's patient advocates say it’s important that patients with Alzheimer’s disease have access to FDA-approved drugs that are covered by Medicare while more than half say they would be more likely to vote for a candidate who supported requiring Medicare to cover those treatments, a study released Tuesday (May 23) found. The LEAD Coalition, Alliance for Aging Research, Global Alzheimer’s Platform Foundation and UsAgainstAlzheimer’s commissioned a telephone and online poll of 1,275 voters...